Ketan Yerneni

Ketan Yerneni is a physician-scientist with a strong background in molecular imaging, translational oncology, and neuroscience research, which he applies to his work in biotech venture capital. He obtained his MD from Northwestern University's Feinberg School of Medicine and a BA in Molecular Biology from Skidmore College. kdtvc+3

As a Principal at KdT Ventures, Ketan focuses on early-stage investments in frontier computational technologies and science, supporting founders who are developing novel medical technologies and medicines to improve patient lives. His investment focus areas include frontier computational technologies and science. kdtvc+3

Ketan is also a Co-Founder of Decoding Bio, a platform dedicated to translating complex biotech and AI developments into accessible content, fostering thoughtful discussion within the industry. decodingbio+1

His prior experience includes business development roles at Rhaeos, where he worked on non-invasive diagnostics for hydrocephalus patients, and Surgical Innovation Associates, where he contributed to improving patient outcomes in reconstructive surgery. nfx+2